Clinical trial
The Effectiveness of Biomimetic Materials in Preventing Enamel Demineralization During Fixed Appliance Orthodontic Treatment: a Randomized Clinical Trial
Name
763423
Description
This study will be done to evaluate the impact of Biosmalto Impact Action Mousse™ on the development and healing of WSLs in individuals receiving orthodontic treatment.
The control group received a fluoridated toothpaste (Colgate toothpaste). The intervention group received Curasept toothpaste and additionally at each visit a Curasept Biosmalto Mousse was applied on the facial surface of the maxillary and mandibular anterior teeth using a tray.
For each patient recruited, identical toothbrushes and oral care instructions were given. The patients received instructions to brush their teeth for at least two minutes using an up-down motion on their anterior teeth and a circular motion on their posterior teeth at least three times/day.
Trial arms
Trial start
2023-01-15
Estimated PCD
2023-10-01
Trial end
2024-01-01
Status
Active (not recruiting)
Treatment
Curasept Biosmalto Mousse and toothpaste
at each visit a Curasept Biosmalto Mousse will be applied on the facial surface of the maxillary and mandibular anterior teeth using a tray.
Arms:
intervention group
Colgate toothpaste
The control group will receive a fluoridated toothpaste (Colgate toothpaste)
Arms:
control group
Size
65
Primary endpoint
WSLs evaluation
6 month
Eligibility criteria
Inclusion Criteria:
* Willingness to participate.
* No underlying medical conditions requiring medications that may cause dryness of the mouth.
* Fully erupted permanent maxillary and mandibular canines and incisors that have not been restored.
Exclusion Criteria:
* Receiving professional fluoridation within the last three months.
* Untreated cavitated lesions or significant restorations on the facial surfaces of study teeth.
* Labial restoration of any of the study teeth.
* Missing any of the study teeth.
* Severely rotated any of the study teeth (limiting the appearance of buccal surfaces).
* Patients with enamel hypoplasia, dental fluorosis or tetracycline pigmentation.
* Dental anomalies related to morphology, anatomy, or development.
* Pregnancy and xerostomia.
* Heavy smokers.
* Craniofacial syndromes such as clefts
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 65, 'type': 'ACTUAL'}}
Updated at
2023-07-11
1 organization
1 product
2 indications
Organization
University of BaghdadProduct
Curasept BiosmaltoIndication
Enamel HypomineralizationIndication
Toothache